|
๐
|
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
13 auth.
T. Schwarz,
N. Aggarwal,
B. Moeckesch,
Isabelle Schenkenberger,
Carine Claeys,
Martine Douha,
O. Godeaux,
K. Grupping,
T. Heineman,
Marta Lรณpez Fauqued,
...
L. Oostvogels,
P. Van den Steen,
Himal Lal
|
5 |
2017 |
5
๐
|
|
๐ฆ
|
Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine
9 auth.
K. Grupping,
L. Cรกmpora,
Martine Douha,
T. Heineman,
N. Klein,
Himal Lal,
...
James T Peterson,
Ilse Vastiau,
L. Oostvogels
|
5 |
2017 |
5
๐ฆ
|
|
๐
|
Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults โฅ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial
8 auth.
O. Godeaux,
Martina Kovac,
D. Shu,
K. Grupping,
L. Cรกmpora,
Martine Douha,
...
T. Heineman,
Himal Lal
|
5 |
2017 |
5
๐
|
|
๐
|
The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial
15 auth.
K. Schmader,
M. Levin,
K. Grupping,
Sean Matthews,
David Butuk,
Michael Chen,
M. E. Idrissi,
Laurence A Fissette,
C. Fogarty,
P. Hartley,
...
N. Klein,
M. Nevarez,
K. Uusinarkaus,
L. Oostvogels,
D. Curran
|
4 |
2018 |
4
๐
|
|
๐ฆ
|
MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
9 auth.
K. Grupping,
P. Selhorst,
J. Michiels,
K. Vereecken,
L. Heyndrickx,
P. Kessler,
...
G. Vanham,
Loiฬc Martin,
K. Ariรซn
|
4 |
2012 |
4
๐ฆ
|
|
๐
|
M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding
8 auth.
P. Selhorst,
K. Grupping,
T. Tong,
E. Crooks,
Loiฬc Martin,
G. Vanham,
...
J. Binley,
K. Ariรซn
|
3 |
2013 |
3
๐
|
|
๐
|
HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing antibodies.
9 auth.
T. Dieltjens,
Nathalie Loots,
K. Vereecken,
K. Grupping,
L. Heyndrickx,
E. Bottieau,
...
G. Vanham,
D. Davis,
W. Janssens
|
3 |
2009 |
3
๐
|
